Skip to main content

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Active, not recruiting · Phase 2 · NCT06598943

Conditions: Ulcerative Colitis, Ulcerative Colitis Chronic

At a glance

Research payments reported, 2025
$891,548
U.S. investigators named
38
Sites paid
36
Planned or actual enrollment
143

About the trial

Sponsor
Eli Lilly and Company
Tested
Eltrekibart (drug), Mirikizumab (drug), Placebo (drug)
Dates
Started 2024-10-10; completion 2027-07
Results posted
Not yet

The main purpose of this study is to determine the safety and efficacy of eltrekibart and mirikizumab in adult participants with moderately to severely active ulcerative colitis (UC).

From ClinicalTrials.gov, last updated 2026-10-07. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Eli Lilly and Company reported $891,548 in research payments for this study in 2025 (39 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Gastroenterology Clinic of San Antonio $108,548
  • Avicenna Clinical Research LLC $69,017
  • Om Research LLC $62,405
  • United Medical Doctors $54,973
  • Peak Gastroenterology Associates $49,574
  • Nodal Medical Center $45,477
  • International Center for Research $42,885
  • Well Pharma Medical Research Corp $32,808
  • Clinnova Research Solutions Corporation $29,900
  • Elias Research Associates LLC $25,866
  • Ivam Clinical and Investigatio $25,456
  • Pioneer Clinical Research Ny $23,772
  • Reserka LLC $23,490
  • Tyler Research Institute LLC $21,938
  • Applied Research Center of Arkansas $20,500
  • Dhr Health Institute for Resea $20,350
  • Baptist Health $18,361
  • Northwestern University $17,556
  • Orlando Health, FL $17,500
  • Baylor College of Medicine $16,750
  • Advanced Research Inc $16,321
  • Clinical Trials Management Services LLC $14,500
  • Gcga Physicians Inc DBA Consultants for Clinical Res $14,500
  • Erick H Alayo Medical Corporate $13,500
  • Az Gastro Care $13,450
  • Valley View Research $13,400
  • Digestive Disease Medicine of Central New York $13,000
  • Florida Digestive Health Specialists LLP $12,640
  • Clinical Trials Management LLC $12,000
  • Research Bay Inc $11,650
  • Southern California Research Center $10,000
  • Prospective Research Innovations Inc $7,705
  • University of North Carolina at Chapel Hill $2,740
  • Care Access Research LLC $2,685
  • Smart Medical Research Inc $2,168
  • $2,163
  • Gastroenterology Associates of Western $2,000

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.